NRG1271 is an orally active mitochondrial permeability transition pore (mPTP) inhibitor with blood-brain barrier penetration. NRG1271 can be used for the study of Neurological Disease[1].
Molecular Weight:
346.31
Purity:
98.86
CAS Number:
[3077720-24-9]
Formula:
C17H13F3N4O
Target:
Mitochondrial Metabolism
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted